arrow
P

Philip R. Debruyne

university hospital leuven
H指数:29
被引数:2,847

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study

帕姆单抗联合每周紫杉醇治疗铂耐药复发性卵巢癌(ENGOT-ov65/KEYNOTE-B96):一项多中心、随机、双盲、III期研究

2026-04-100
PRE
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors

晚期实体瘤患者AXL特异性抗体药物偶联物Enapotamab Vedotin的I/II期研究

2025-11-010
OA
Targeting Fear of Cancer Recurrence with Internet-Based Emotional Freedom Techniques (iEFT) and Mindfulness Meditation Intervention (iMMI) (BGOG-gyn1b-REMOTE)

针对癌症复发恐惧的基于互联网的情感自由技术(iEFT)和正念冥想干预(iMMI)(BGOG-gyn1b-REMOTE)

2025-08-230
PRE
Real-world usage and adverse events (AE) of immune checkpoint inhibitors (ICI): A large-scale, automated, GDPRcompliant analysis of hospital records

真实世界使用和免疫检查点抑制剂(ICI)的不良事件(AE):一项大规模、自动化的GDPR合规性医院记录分析

2024-09-010
PRE
Pemigatinib for metastatic or surgically unresectable urothelial carcinoma with FGF/FGFR genomic alterations: final results from FIGHT-201

Pemigatinib治疗转移性或手术不可切除的尿路上皮癌伴FGF/FGFR基因组改变: 来自FIGHT-201的最终结果

2024-02-018
OAAI
Long-term health-care utilisation in older patients with cancer and the association with the Geriatric 8 screening tool: a retrospective analysis using linked clinical and population-based data in Belgium

老年癌症患者的长期医疗保健利用及其与老年筛查工具的关联: 使用比利时的关联临床和基于人群的数据进行的回顾性分析

2023-07-017
OA
Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes

将比利时老年癌症患者的临床和基于人群的数据联系起来: 可行性和临床结果

2023-03-013
PRE
Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer: a multicenter study

老年体弱癌症患者跌倒和跌倒相关伤害的发生率及其预测因素: 一项多中心研究

2022-11-1915
OAAI
Functional status in older patients with cancer and a frailty risk profile: A multicenter observational study

老年癌症患者的功能状态和脆弱风险状况: 一项多中心观察性研究

2022-11-019
OA
Primary analysis from DS8201-A-U105: A 2-part, open label, phase Ib trial assessing trastuzumab deruxtecan (T-DXd) with nivolumab (nivo) in patients (pts) with HER2-expressing advanced breast cancer
2022-05-0125
OA
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial
2021-11-0145
PREAI
Unplanned hospitalizations in older patients with cancer: Occurrence and predictive factors
2021-04-0119
OAAI
The prognostic value of patient-reported Health-Related Quality of Life and Geriatric Assessment in predicting early death in 6769 older (≥70 years) patients with different cancer tumors
2020-07-018
PREAI